FDA NDC Directory · JSON-LD · Markdown

Irbesartan

NDC 33342-048 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerMacleods Pharmaceuticals Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA202254
Dosage form / routeTABLET · ORAL
Active ingredientsIRBESARTAN (150 mg/1)
Marketing started20120927
Package count5

External sources

Source: openFDA. Public-domain (CC0).